Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment

Tumor microenvironment has been implicated in tumor development and progression. As a three-dimensional tumor microenvironment model, air liquid interface (ALI) organoid culture from oncogene transgenic mouse gastrointestinal tissues was recently produced. However, ALI organoid culture system from tissues of colorectal cancer patients has not been established. Here, we developed an ALI organoid model from normal and tumor colorectal tissues of human patients. Both organoids were successfully generated and showed cystic structures containing an epithelial layer and surrounding mesenchymal stromal cells. Structures of tumor organoids closely resembled primary tumor epithelium. Expression of an epithelial cell marker, E-cadherin, a goblet cell marker, MUC2, and a fibroblast marker, vimentin, but not a myofibroblast marker, α-smooth muscle actin (SMA), was observed in normal organoids. Expression of E-cadherin, MUC2, vimentin, and α-SMA was observed in tumor organoids. Expression of a cancer stem cell marker, LGR5 in tumor organoids, was higher than that in primary tumor tissues. Tumor organoids were more resistant to toxicity of 5-fluorouracil and Irinotecan than colorectal cancer cell lines, SW480, SW620, and HCT116. These findings indicate that ALI organoid culture from colorectal cancer patients may become a novel model that is useful for examining resistance to chemotherapy in tumor microenvironment.

[1]  R. Flavell,et al.  Fibroblasts and myofibroblasts of the intestinal lamina propria in physiology and disease. , 2016, Differentiation; research in biological diversity.

[2]  Yuhong Bian,et al.  Isolation of colorectal cancer stem-like cells , 2016, Cytotechnology.

[3]  N. Wright,et al.  Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. , 2007, Pharmacology & therapeutics.

[4]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[5]  R. Hynds,et al.  Concise Review: The Relevance of Human Stem Cell‐Derived Organoid Models for Epithelial Translational Medicine , 2013, Stem cells.

[6]  C. Houchen,et al.  Intestinal stem cells and the colorectal cancer microenvironment. , 2014, World journal of gastroenterology.

[7]  D. Scadden,et al.  The stem-cell niche as an entity of action , 2006, Nature.

[8]  A. Levine,et al.  LGR5‐Positive Colon Cancer Stem Cells Interconvert with Drug‐Resistant LGR5‐Negative cells and are Capable of Tumor Reconstitution , 2012, Stem cells.

[9]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[10]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[11]  H. Moses,et al.  Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta , 1987, Journal of Experimental Medicine.

[12]  Calvin J Kuo,et al.  Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche , 2009, Nature Medicine.

[13]  B. Calenic,et al.  Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. , 2014, World journal of gastroenterology.

[14]  S. Toda,et al.  Establishment of a long-term three-dimensional primary culture of mouse glandular stomach epithelial cells within the stem cell niche. , 2013, Biochemical and biophysical research communications.

[15]  Olivier De Wever,et al.  Stromal myofibroblasts are drivers of invasive cancer growth , 2008, International journal of cancer.

[16]  Hayley E. Francies,et al.  Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.

[17]  Z. Kozovska,et al.  Colon cancer: cancer stem cells markers, drug resistance and treatment. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Ying Liang,et al.  Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer , 2013, International Journal of Colorectal Disease.

[19]  A. Russo,et al.  Multisciplinary management of patients with liver metastasis from colorectal cancer. , 2016, World journal of gastroenterology.

[20]  M. Jauberteau,et al.  Hallmarks in colorectal cancer: angiogenesis and cancer stem-like cells. , 2014, World journal of gastroenterology.

[21]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[22]  J. Samra,et al.  Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review , 2016, Oncotarget.

[23]  K. Okamoto,et al.  [Spontaneously hypertensive rats]. , 1972, Nihon rinsho. Japanese journal of clinical medicine.

[24]  Olivier Gevaert,et al.  Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture , 2014, Nature Medicine.

[25]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[26]  Fei Liu,et al.  Biomechanical regulation of mesenchymal cell function , 2013, Current opinion in rheumatology.

[27]  Hans Clevers,et al.  EVIEWS IN BASIC AND CLINICAL ASTROENTEROLOGY , 2008 .

[28]  M. Okada,et al.  Death-Associated Protein Kinase 3 Mediates Vascular Inflammation and Development of Hypertension in Spontaneously Hypertensive Rats , 2012, Hypertension.

[29]  H. Clevers,et al.  Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications , 2013, Science.

[30]  C. Hofmann,et al.  Transforming growth factor-beta 1 induces intestinal myofibroblast differentiation and modulates their migration. , 2009, World journal of gastroenterology.

[31]  Julian Lewis,et al.  Organizing cell renewal in the intestine: stem cells, signals and combinatorial control , 2006, Nature Reviews Genetics.